Stockholders' Equity Note Disclosure [Text Block] | NOTE 14 - STOCKHOLDERS' EQUITY Common Stock -- Voting -- Dividends -- Liquidation Rights -- Other Matters -- Preferred Stock -- Common Stock Issuance On August 14, 2015, the Company issued an additional 27,253 shares of restricted stock valued at $20,167 for services provided and to be provided by the Board of Directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which 27,253 shares vested on January 1, 2016. On April 13, 2015, the Company issued an additional 100,000 shares of restricted stock valued at $75,000 for services provided and to be provided by the Board of Directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which 33,333 shares vested on January 1, 2016, 33,333 shares will vest on January 1, 2017 and 33,334 shares will vest on January 1, 2018. For the nine months ended September 30, 2016 and 2015, the Company has recorded non-cash compensation expense of $58,250 and $146,250 relating to the awards, respectively. Common Stock Purchase Warrants A summary of the status of the warrants outstanding at September 30, 2016 is presented below: Warrants Outstanding Warrants Exercisable Exercise Prices Number Outstanding Weighted Average Remaining Contractual Life (years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.81 100,000 1.25 $ 0.81 100,000 $ 0.81 $ 1.00 200,000 1.25 $ 1.00 133,333 $ 1.00 $ 1.50 3,874,000 0.25 $ 1.50 3,874,000 $ 1.50 $ 1.65 400,000 2.83 $ 1.65 400,000 $ 1.65 $ 2.70 2,626,000 0.25 $ 2.70 2,626,000 $ 2.70 $ 4.06 125,575 0.44 $ 4.06 125,575 $ 4.06 Total 7,325,575 0.44 $ 1.96 7,258,908 $ 1.97 At September 30, 2016, the Company had 66,667 non-vested warrants. We have recorded non-cash compensation expense of $46,225 for the nine months ended September 30, 2016 related to the warrants issued. The exercise price of the warrants and the number of shares underlying the warrants are subject to adjustment for stock dividends, subdivisions of the outstanding shares of common stock and combinations of the outstanding shares of common stock. For so long as the warrants remain outstanding, we are required to keep reserved from our authorized and unissued shares of common stock a sufficient number of shares to provide for the issuance of the shares underlying the warrants. On February 15, 2016, the Company issued to LCL Finance Limited a warrant to purchase 100,000 shares at an exercise price of $0.81 per share. The warrants are exercisable immediately and will remain exercisable until December 31, 2017. On June 4, 2015, the Company issued to Wolfe Axelrod Weinberger Associates, LLC a warrant to purchase 200,000 shares at an exercise price of $1.00 per share. The warrants vested 1/3 upon issuance, 1/3 on June 4, 2016, 1/3 will vest on June 2017, and will remain exercisable until December 31, 2017. Stock Options In August 2011, Parent’s Board of Directors adopted a Stock Option Plan (the “Plan”). Under the terms and conditions of the Plan, the Board of Directors is empowered to grant stock options to employees, officers, and directors of the Company. At September 30, 2016, 1,046,000 options were granted and outstanding under the Plan. The Company recognizes compensation costs for stock option awards to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average assumptions used to estimate the fair values of the stock options granted using the Black-Scholes option-pricing model are as follows: LiqTech International, Inc. Expected term (in years) 5 - 10 Volatility 74.65 % - 76.87% Risk free interest rate 1.38 % - 2.24% Dividend yield 0% The Company recognized stock based compensation expense related to the options of $272,665 and $112,528 for the nine months ended September 30, 2016 and 2015, respectively. At September 30, 2016 the Company had approximately $260,734 of unrecognized compensation cost related to non-vested options expected to be recognized through December 31, 2025. A summary of the status of the options outstanding under the Plan at September 30, 2016 is presented below: Options Outstanding Options Exercisable Exercise Prices Number Outstanding Weighted Average Remaining Contractual Life (years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.74 400,000 3.87 $ 0.74 133,333 $ 0.74 $ 0.75 100,000 3.54 $ 0.75 33,333 $ 0.75 $ 1.01 130,000 9.22 $ 1.01 130,000 $ 1.01 $ 1.57 100,000 1.04 $ 1.57 100,000 $ 1.57 $ 1.90 316,000 0.33 $ 1.90 316,000 $ 1.90 Total 1,046,000 3.16 $ 1.20 712,666 $ 1.42 A summary of the status of the options at September 30, 2016, and changes during the period are presented below: September 30, 2016 Shares Weighted Average Exercise Price Average Remaining Life Weighted Average Intrinsic Value Outstanding at beginning of period 1,071,000 $ 1.19 3.93 $ - Granted - - - - Exercised - - - - Forfeited (25,000 ) 0.74 - - Expired - - - - Outstanding at end of period 1,046,000 $ 1.20 3.16 $ 44,000 Vested and expected to vest 1,046,000 $ 1.20 3.16 $ 44,000 Exercisable end of period 712,666 $ 1.42 2.86 $ 14,667 At September 30, 2016, the Company had 333,334 non-vested options with a weighted average exercise price of $0.74 and with a weighted average grant date fair value of $0.46, resulting in unrecognized compensation expense of $75,274, which is expected to be expensed over a weighted-average period of 1.75 years. The total intrinsic value of options at September 30, 2016 was $44,000. Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at September 30, 2016 (for outstanding options), less the applicable exercise price. |